John R. Schroer, the Chief Financial Officer of $ALMS, sold 3,282 shares of the company on 08-03-2026 for an estimated $86,546. We received data on the trade from a recent SEC filing. This was a sale of approximately 11.7% of their shares of this class of stock. Following this trade, they now own 24,718 shares of this class of $ALMS stock.
$ALMS Insider Trading Activity
$ALMS insiders have traded $ALMS stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $ALMS stock by insiders over the last 6 months:
- SANAM PANGALI (Chief Legal Officer) has made 0 purchases and 2 sales selling 6,364 shares for an estimated $175,968.
- JOHN R. SCHROER (Chief Financial Officer) sold 3,282 shares for an estimated $86,546
- ROY C. HARDIMAN (Chief Business & Strategy Ofcr) sold 2,692 shares for an estimated $70,988
- DAVID M GOLDSTEIN (Chief Scientific Officer) sold 2,596 shares for an estimated $68,456
- MARK CHRISTOPHER BRADLEY (Chief Development Officer) sold 2,572 shares for an estimated $67,823
- JORN DRAPPA (Chief Medical Officer) sold 2,447 shares for an estimated $64,527
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ALMS Hedge Fund Activity
We have seen 123 institutional investors add shares of $ALMS stock to their portfolio, and 56 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEEP TRACK CAPITAL, LP added 6,772,595 shares (+inf%) to their portfolio in Q1 2026, for an estimated $149,200,267
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,236,331 shares (+6418.5%) to their portfolio in Q1 2026, for an estimated $71,296,371
- UBS GROUP AG added 2,940,868 shares (+2579.8%) to their portfolio in Q1 2026, for an estimated $64,787,322
- BLACKROCK, INC. added 2,604,366 shares (+57.0%) to their portfolio in Q1 2026, for an estimated $57,374,182
- IKARIAN CAPITAL, LLC added 1,213,548 shares (+inf%) to their portfolio in Q1 2026, for an estimated $26,734,462
- WEISS ASSET MANAGEMENT LP added 1,097,417 shares (+inf%) to their portfolio in Q1 2026, for an estimated $24,176,096
- FMR LLC added 949,795 shares (+3959.6%) to their portfolio in Q1 2026, for an estimated $20,923,983
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$ALMS Price Targets
Multiple analysts have issued price targets for $ALMS recently. We have seen 8 analysts offer price targets for $ALMS in the last 6 months, with a median target of $42.0.
Here are some recent targets:
- Janani Sundararajan from Chardan Capital set a target price of $40.0 on 05/19/2026
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $25.0 on 05/15/2026
- Derek Archila from Wells Fargo set a target price of $51.0 on 05/15/2026
- Yatin Suneja from Guggenheim set a target price of $34.0 on 05/15/2026
- Jeff Jones from Oppenheimer set a target price of $55.0 on 03/30/2026
- Terence Flynn from Morgan Stanley set a target price of $38.0 on 03/20/2026
- Christopher Raymond from Raymond James set a target price of $46.0 on 03/11/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
